Favorable response to pembrolizumab after durvalumab...

BMC Pharmacology and Toxicology 2020 / 12 Vol. 21; Iss. 1

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report

Nishino, Kazumi, Kunimasa, Kei, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Kuhara, Hanako, Kumagai, Toru
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
BMC Pharmacology and Toxicology
DOI:
10.1186/s40360-020-00404-7
Date:
December, 2020
File:
PDF, 1.27 MB
2020
Conversion to is in progress
Conversion to is failed